The latest on artificial intelligence transforming medicine

AI Drug Discovery’s Real Challenge Is No Longer Prediction but Execution

A new CHEManager analysis argues that aligning AI with laboratory execution is now the central challenge in drug discovery. The point captures a broad industry turn: value increasingly depends on whether models can be embedded in reliable experimental loops, not merely whether they produce impressive in silico outputs.